Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI-Reference-Cited by-同舟云学术

Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI

Published:2017-03-09 Issue:4 Volume:28 Page:1031-1040
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Han Zheng¹,Li Yajuan²,Roelle Sarah¹,Zhou Zhuxian¹,Liu Yuchi¹,Sabatelle Rob¹,DeSanto Aidan¹,Yu Xin¹,Zhu Hui,Magi-Galluzzi Cristina,Lu Zheng-Rong¹^ORCID

Affiliation:

1. Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, United States

2. Molecular Theranostics, LLC, Beachwood, Ohio 44122, United States

Funder

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.6b00719

Reference40 articles.

1. Perspective: Enforce the clinical guidelines